---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-050819"
form_type: "8-K"
ticker: "CLSDQ"
cik: "0001539029"
company_name: "Clearside Biomedical, Inc."
filed_at: "2023-09-29T23:59:59+00:00"
generated_at: "2026-06-10T06:54:46.976342+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Clearside Biomedical receives Nasdaq delisting notice for bid price below $1.00

## Summary
- Received Nasdaq notice on Sept 27, 2023 for non-compliance with minimum bid price rule.
- Must regain compliance by March 25, 2024; bid price must close at $1.00+ for 10 consecutive days.
- May transfer to Nasdaq Capital Market or effect a reverse stock split to cure the deficiency.
- Failure to regain compliance could lead to delisting, impairing liquidity and capital access.

## SEC filing metadata
- accession: 0000950170-23-050819
- form_type: 8-K
- ticker: CLSDQ
- cik: 0001539029
- company_name: Clearside Biomedical, Inc.
- filed_at: 2023-09-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1539029/000095017023050819/0000950170-23-050819-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1539029/000095017023050819/clsd-20230927.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-050819
- JSON: https://secwatch.observer/filing/0000950170-23-050819.json
- Plain text: https://secwatch.observer/filing/0000950170-23-050819.txt

## Key facts
- Listing & Compliance Notices
  Clearside Biomedical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1), 5810(c)(3)(A)
  source text: September 27, 2023, Clearside Biomedical, Inc. (the “ Company ”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that the listing of its common stock was not in compliance with Nasdaq Listing Rule 5450(a)(1) for continued listing on the Nasdaq Global Market, as the minimum bid price of the Company’s common stock was less than $1.00 per share for the previous 30 consecutive business days. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days, or until March 25, 2024, to regain complia
  evidence_url: https://www.sec.gov/Archives/edgar/data/1539029/000095017023050819/0000950170-23-050819-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.